Decoy Therapeutics is trading 8.2% down at $4.01 today, extending yesterday’s consolidation after a sharp rebound from late-July lows.
- There is currently no new company-specific news, earnings, or analyst actions explaining the drop.
- The price action suggests a continuation of recent technical and volatility-driven trading rather than a fundamental shift in the company's outlook.